Floyd Regulatory Strategic Consulting

Floyd Regulatory Strategic Consulting is a specialized regulatory affairs advisory firm founded and led by Dr. Eric Floyd. The firm provides strategic regulatory guidance to clinical-stage biotechnology and pharmaceutical companies, with a particular focus on central nervous system (CNS), oncology, and rare disease therapeutic areas. Its expertise encompasses IND strategy, FDA engagement and meeting management, clinical protocol regulatory review, and NDA/BLA planning and submission management. The consultancy is known for its lean operating model and its ability to support companies through complex regulatory pathways toward product approval.